Posted by Michael Wonder on 25 Jul 2019
Drug pricing policy means deciding when to say “no”
25 July 2019 - Today, the Senate Finance Committee holds hearings to markup its ambitious drug pricing overhaul package.
This represents perhaps the clearest and more comprehensive drug pricing legislative package to date. Rather than detailing each provision of the package, which is likely to meaningfully change throughout the legislative process, it’s useful to take a step back and consider a framework for evaluating the economic fundamentals driving drug pricing policy.
Experts like to say drug pricing is complicated.
